Association between APOBEC3s and HPV16 E2 gene hypermutation in Uygur females with cervical cancer

被引:4
|
作者
Sui, Shuang [1 ]
Jiao, Zhen [1 ]
Chen, Hongxiang [1 ]
Niyazi, Mayinuer [1 ]
Wang, Lin [1 ]
机构
[1] Peoples Hosp Xinjiang Uygur Autonomous Reg, Dept Obstet & Gynecol, 91 Tianchi Rd, Urumqi 830001, Xinjiang Uygur, Peoples R China
基金
中国国家自然科学基金;
关键词
cervical cancer; apolipoprotein B mRNA-editing enzyme catalytic polypeptides; HPV16; E2; gene; hypermutation; human papilloma virus; SIMPLEX-VIRUS; 1; MUTATIONAL PROCESSES; CYTIDINE DEAMINASES; PAPILLOMAVIRUS; DNA; EXPRESSION; MUTAGENESIS; INFECTION; PROTEINS; GENOMES;
D O I
10.3892/ol.2020.11697
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The present study aimed to investigate whether apolipoprotein B mRNA-editing enzyme catalytic polypeptides (A3) are involved in the regulation of cervical cancer development and human papilloma virus (HPV)16 sustained infection in Uighur females. Cervical tissues of Uygur patients with HPV16 with cervical lesions were collected. Expression levels of A3C, A3F and A3G were detected using reverse transcription-quantitative PCR and western blotting. A model of SiHa cells with high expression levels of A3C, A3F and A3G was constructed. Hypermutation was detected using the differential DNA denaturation PCR and positive samples were amplified and sequenced. There were significant differences in A3 expression levels in cervical lesions of different grades. A3C and A3F mRNA and protein expression in cervical cancer tissues were significantly lower, whereas the A3G mRNA and protein expression levels were significantly higher compared with the cervicitis and cervical intraepithelial neoplasia (CIN) I-III groups. Hypermutation rates were increased with cervical lesion development. C>T and G>A base substitutions were detected in all hypermutation samples and numbers of C>T and G>A base substitutions in single samples in the cervical cancer group were significantly higher compared with those in the CIN I-III and cervicitis groups. Following transfection of A3F and A3G, HPV E2 mRNA and protein expression levels were significantly decreased in SiHa cells. Numerous C>T and G>A base substitutions were detected in the HPV E2 gene in A3G and A3C overexpressing SiHa cells. A3 family proteins inhibit viral replication during HPV16 infection and regulate the HPV16 integration by inducing C>T and G>A hypermutations in the HPV16 E2 gene, thus affecting the cervical cancer pathogenesis and development.
引用
收藏
页码:1752 / 1760
页数:9
相关论文
共 50 条
  • [41] PinX1, a novel target gene of p53, is suppressed by HPV16 E6 in cervical cancer cells
    Wu, Gengze
    Liu, Dongbo
    Jiang, Ke
    Zhang, Li
    Zeng, Yijun
    Zhou, Peng
    Zhong, Dan
    Gao, Min
    He, Fengtian
    Zheng, Yingru
    BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS, 2014, 1839 (02): : 88 - 96
  • [42] Targeting hexokinase 2 inhibition promotes radiosensitization in HPV16 E7-induced cervical cancer and suppresses tumor growth
    Liu, Yuan
    Murray-Stewart, Tracy
    Casero, Robert A.
    Kagiampakis, Ioannis
    Jin, Lihua
    Zhang, Jiawen
    Wang, Huihui
    Che, Qi
    Tong, Huan
    Ke, Jieqi
    Jiang, Feizhou
    Wang, Fangyuan
    Wan, Xiaoping
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2017, 50 (06) : 2011 - 2023
  • [43] Combined prophylactic and therapeutic cancer vaccine: Enhancing CTL responses to HPV16 E2 using a chimeric VLP in HLA-A2 mice
    Qian, JH
    Dong, YJ
    Pang, YYS
    Ibrahim, R
    Berzofsky, JA
    Schiller, JT
    Khleif, SN
    INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (12) : 3022 - 3029
  • [44] Effectiveness of HPV 16 viral load and the E2/E6 ratio for the prediction of cervical cancer risk among Chinese women
    Chang, Lihong
    He, Xiaoxiao
    Yu, Guifang
    Wu, Yuping
    JOURNAL OF MEDICAL VIROLOGY, 2013, 85 (04) : 646 - 654
  • [45] Viral DNA load, physical status and E2/E6 ratio as markers to grade HPV16 positive women for high-grade cervical lesions
    Cricca, Monica
    Morselli-Labate, Antonio Maria
    Venturoli, Simona
    Ambretti, Simone
    Gentilomi, Giovanna Angela
    Gallinella, Giorgio
    Costa, Silvano
    Musiani, Monica
    Zerbini, Marialuisa
    GYNECOLOGIC ONCOLOGY, 2007, 106 (03) : 549 - 557
  • [46] HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3
    Yin, Fufen
    Wang, Ning
    Wang, Shanshan
    Yu, Fengsheng
    Sun, Xin
    Yu, Xiao
    Luo, Bing
    Zhao, Chengquan
    Wang, Yankui
    ONCOLOGY REPORTS, 2017, 37 (04) : 2324 - 2334
  • [47] Distinct regulation and impact of type 1 T-cell immunity against HPV16 L1, E2 and E6 antigens during HPV16-induced cervical infection and neoplasia
    van Poelgeest, MIE
    Nijhuis, ER
    Kwappenberg, KMC
    Hamming, IE
    Drijfhout, JW
    Fleuren, GJ
    van der Zee, AGJ
    Melief, CJM
    Kenter, GG
    Nijman, HW
    Offringa, R
    van der Burg, SH
    INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (03) : 675 - 683
  • [48] Cancer stages and demographical study of HPV16 in gene L2 isolated from cervical cancer in Dhi-Qar province, Iraq
    Jalil, Abduladheem Turki
    Kadhum, Wesam R.
    Faryad Khan, Muhammad Usman
    Karevskiy, Aleksandr
    Hanan, Zaman K.
    Suksatan, Wanich
    Waheeb, Azal Shakir
    Awad, Masar Ali
    Abdullah, Mays Mohammed
    APPLIED NANOSCIENCE, 2021, 13 (5) : 3627 - 3627
  • [49] Re-expression of HPV16 E2 in SiHa (human cervical cancer) cells potentiates NF-κB activation induced by TNF-α concurrently increasing senescence and survival
    Prabhavathy, Devan
    Subramanian, Chandrasekaran Karthik
    Karunagaran, Devarajan
    BIOSCIENCE REPORTS, 2015, 35
  • [50] Association of antibody to E2 protein of human papillomavirus and p16INK4A with progression of HPV-infected cervical lesions
    Chuerduangphui, Jureeporn
    Pientong, Chamsai
    Swangphon, Piyawut
    Luanratanakorn, Sanguanchoke
    Sangkomkamhang, Ussanee
    Tungsiriwattana, Thumwadee
    Kleebkaow, Pilaiwan
    Burassakarn, Ati
    Ekalaksananan, Tipaya
    MEDICAL ONCOLOGY, 2018, 35 (06)